Authors:
LADURNER AG
ITZHAKI LS
DAGGETT V
FERSHT AR
Citation: Ag. Ladurner et al., SYNERGY BETWEEN SIMULATION AND EXPERIMENT IN DESCRIBING THE ENERGY LANDSCAPE OF PROTEIN-FOLDING, Proceedings of the National Academy of Sciences of the United Statesof America, 95(15), 1998, pp. 8473-8478
Citation: Ag. Ladurner et al., COMPLEMENTATION OF PEPTIDE-FRAGMENTS OF THE SINGLE-DOMAIN PROTEIN CHYMOTRYPSIN INHIBITOR-2, Journal of Molecular Biology, 273(1), 1997, pp. 317-329
Citation: Ag. Ladurner et Ar. Fersht, GLUTAMINE, ALANINE OR GLYCINE REPEATS INSERTED INTO THE LOOP OF A PROTEIN HAVE MINIMAL EFFECTS ON STABILITY AND FOLDING RATES, Journal of Molecular Biology, 273(1), 1997, pp. 330-337
Authors:
NEIRA JL
ITZHAKI LS
LADURNER AG
DAVIS B
GAY GD
FERSHT AR
Citation: Jl. Neira et al., FOLLOWING COOPERATIVE FORMATION OF SECONDARY AND TERTIARY STRUCTURE IN A SINGLE PROTEIN MODULE, Journal of Molecular Biology, 268(1), 1997, pp. 185-197
Authors:
NEIRA JL
DAVIS B
LADURNER AG
BUCKLE AM
GAY GD
FERSHT AR
Citation: Jl. Neira et al., TOWARDS THE COMPLETE STRUCTURAL CHARACTERIZATION OF A PROTEIN-FOLDINGPATHWAY - THE STRUCTURES OF THE DENATURED, TRANSITION AND NATIVE STATES FOR THE ASSOCIATION FOLDING OF 2 COMPLEMENTARY FRAGMENTS OF CLEAVEDCHYMOTRYPSIN INHIBITOR .2. DIRECT EVIDENCE FOR A NUCLEATION-CONDENSATION MECHANISM/, Folding & design, 1(3), 1996, pp. 189-208
Authors:
GAY GD
RUIZSANZ J
NEIRA JL
CORRALES FJ
OTZEN DE
LADURNER AG
FERSHT AR
Citation: Gd. Gay et al., CONFORMATIONAL PATHWAY OF THE POLYPEPTIDE-CHAIN OF CHYMOTRYPSIN INHIBITOR-2 GROWING FROM ITS N-TERMINUS IN-VITRO - PARALLELS WITH THE PROTEIN-FOLDING PATHWAY, Journal of Molecular Biology, 254(5), 1995, pp. 968-979
Citation: Je. Park et al., INVESTIGATION OF THE DIFFERENTIAL AGONIST SENSITIVITY OF A CLONED BETA-3-ADRENOCEPTOR MEASURED IN 2 FUNCTIONAL ASSAYS, British Journal of Pharmacology, 114, 1995, pp. 431-431